Conditions: Common Cold
Allocation: NON_RANDOMIZED | Intervention model: PARALLEL
Enrollment: 36
Healthy volunteers: yes

Brief summary:
The main purpose of this study is to evaluate the safety of nasal glucagon (NG) in participants with a common cold, some of whom will also take a nasal decongestant. The study will investigate how the body processes NG and the effect of NG on the body. The study will last up to 30 days for each participant.

Detailed description:

Arms:
arm 1: Cohort 1 - Nasal Glucagon (NG) administered once in participants with a common cold. arm 2: Cohort 1 - NG administered once in participants who have recovered from a common cold. arm 3: Cohort 2 - NG administered once in participants with a common cold who are taking oxymetazoline.

Interventions: intervention 1: Nasal Glucagon intervention 2: Oxymetazoline
Intervention descriptions: intervention 1: Administered intranasally. intervention 2: Administered intranasally.

Protocol document: